Terms: = Lymphoma AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Prognosis
212 results:
1. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract] [Full Text] [Related]
2. Differential Upregulation of Th1/Th17-Associated Proteins and pd-l1 in Granulomatous Mycosis Fungoides.
Marques-Piubelli ML; Navarrete J; Ledesma DA; Hudgens CW; Lazcano RN; Alani A; Huen A; Duvic M; Nagarajan P; Aung PP; Wistuba II; Curry JL; Miranda RN; Torres-Cabala CA
Cells; 2024 Feb; 13(5):. PubMed ID: 38474383
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between PD-1 and spd-l1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics.
Wang L; Cao C; Qiu J; Zhang J; He Q; Song L; Xie L; Ma J
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):44-50. PubMed ID: 38430041
[TBL] [Abstract] [Full Text] [Related]
4. Epstein-Barr Virus Promotes Tumorigenicity and Worsens Hodgkin lymphoma prognosis by Activating JAK/STAT and NF-κB Signaling Pathways.
Alabiad MA; Said WMM; Saad RHF; Balata R; Mahmoud AA; Metwally EA; Shalaby AM; Samy W; Yehia AM; Yahia AIO; Alorini M; Abdelrahman DI
Iran J Med Sci; 2024 Feb; 49(2):88-100. PubMed ID: 38356485
[TBL] [Abstract] [Full Text] [Related]
5. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
6. Frequent expression of pd-l1 in BLS-type diffuse large B-cell lymphoma: implications for aggressiveness and immunotherapy.
Yang CF; Yu YT; Wang SH; Chen YP; Chen TY; Hsu CY; Medeiros LJ; Chang KC
Pathology; 2024 Apr; 56(3):367-373. PubMed ID: 38290893
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients.
Shimasaki Y; Miyoshi H; Kawamoto K; Yoshida N; Mishina T; Nakashima K; Imamoto T; Sugio T; Yanagida E; Kato T; Yamada K; Takeuchi M; Suzuki T; Moritsubo M; Furuta T; Imaizumi Y; Takizawa J; Kato K; Suzumiya J; Suzuki R; Ohshima K
Cancer Med; 2024 Feb; 13(3):e6793. PubMed ID: 38234210
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
9. Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult T-cell leukemia/lymphoma.
Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
[TBL] [Abstract] [Full Text] [Related]
10. Digital and manual interfollicular Ki-67 are associated with a progression-free survival in patients with low-grade follicular lymphoma.
Nasir A; Hegerova L; Yousaf H; Forster CL; Shanley R; Linden MA; Bachanova V; Yohe S
Am J Clin Pathol; 2024 Apr; 161(4):380-387. PubMed ID: 38044670
[TBL] [Abstract] [Full Text] [Related]
11. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract] [Full Text] [Related]
12. A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma.
Zhao Z; Shen X; Zhao S; Wang J; Tian Y; Wang X; Tang B
Aging (Albany NY); 2023 Nov; 15(22):12927-12951. PubMed ID: 37976136
[TBL] [Abstract] [Full Text] [Related]
13. Expression of PD-1/pd-l1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma.
Feng X; Luo X; Yang Y; Fan Y; Ye Q
Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048
[TBL] [Abstract] [Full Text] [Related]
14. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway.
Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
Int Immunopharmacol; 2023 Dec; 125(Pt A):111125. PubMed ID: 37907047
[TBL] [Abstract] [Full Text] [Related]
15. High pdl1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Camus V; Viailly PJ; Drieux F; Veresezan EL; Sesques P; Haioun C; Durot E; Patey M; Rossi C; Martin L; Rainville V; Bohers E; Ruminy P; Penther D; Kaltenbach S; Bruneau J; Paillassa J; Tournilhac O; Willaume A; Antier C; Lazarovici J; Lévêque E; Decazes P; Becker S; Tonnelet D; Berriolo-Riedinger A; Gaulard P; Tilly H; Molina TJ; Traverse-Glehen A; Jardin F
Blood Adv; 2023 Dec; 7(23):7331-7345. PubMed ID: 37862676
[TBL] [Abstract] [Full Text] [Related]
16. Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.
Martínez LE; Magpantay LI; Guo Y; Hegde P; Detels R; Hussain SK; Epeldegui M
Front Immunol; 2023; 14():1259007. PubMed ID: 37809067
[TBL] [Abstract] [Full Text] [Related]
17. Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of pd-l1 Blockade in Diffuse Large B-cell lymphoma.
Cai Y; Chen X; Lu T; Fang X; Ding M; Yu Z; Hu S; Liu J; Zhou X; Wang X
Int J Biol Sci; 2023; 19(14):4627-4643. PubMed ID: 37781035
[TBL] [Abstract] [Full Text] [Related]
18. Tislelizumab augment the efficacy of CD19/22 dual-targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B-cell non-Hodgkin lymphoma.
Zhang Y; Geng H; Zeng L; Li J; Yang Q; Jia S; Zong X; Cai W; Liu S; Lu Y; Yu L; Li C; Wu D
Hematol Oncol; 2024 Jan; 42(1):e3227. PubMed ID: 37776326
[TBL] [Abstract] [Full Text] [Related]
19. Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin lymphoma as Prognostic Factor.
Bouzari B; Basi A; Dadkhah S; Panahi M; Mohammadi S
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2829-2835. PubMed ID: 37642071
[TBL] [Abstract] [Full Text] [Related]
20. An integrative bioinformatics investigation and experimental validation of chromobox family in diffuse large B-cell lymphoma.
Zhou F; Chen L; Lu P; Cao Y; Deng C; Liu G
BMC Cancer; 2023 Jul; 23(1):641. PubMed ID: 37430195
[TBL] [Abstract] [Full Text] [Related]
[Next]
